financetom
Business
financetom
/
Business
/
Cloudflare's Growth Acceleration Reinforces Long-Term Opportunity, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cloudflare's Growth Acceleration Reinforces Long-Term Opportunity, RBC Says
Oct 31, 2025 9:02 AM

11:41 AM EDT, 10/31/2025 (MT Newswires) -- Cloudflare ( NET ) delivered another "clean and impressive" quarter, marking its second straight period of accelerating revenue growth and reinforcing confidence in its long-term opportunity, RBC Capital Markets said in a Friday note.

Revenue rose 31% year over year to $562 million, outpacing consensus, while adjusted earnings of $0.27 per share also topped estimates. The company guided for Q4 revenue of about $589 million and EPS of $0.27, both above prior expectations.

The brokerage RBC highlighted stronger enterprise demand, improving sales execution, and broad platform adoption as key drivers of growth. Dollar-based net retention improved to 119% from 114% in the prior quarter, supported by continued momentum in Workers, security products, and AI-related services.

Cloudflare ( NET ) raised its full-year revenue outlook to about $2.14 billion, up roughly 28%, and reaffirmed its long-term targets of a $3 billion annualized run rate by Q4 2026 and $5 billion by 2028.

The firm maintained its outperform rating on the stock and lifted its price target to $265 from $250, calling Cloudflare ( NET ) a top long-term idea.

Shares of Cloudflare ( NET ) jumped more than 12% in recent trading.

Price: 250.29, Change: +27.79, Percent Change: +12.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA expands use of Amgen, AstraZeneca's drug for sinus infection
US FDA expands use of Amgen, AstraZeneca's drug for sinus infection
Oct 17, 2025
Oct 17 (Reuters) - The U.S. Food and Drug Administration has approved Amgen ( AMGN ) and AstraZeneca's ( AZN ) drug for a type of chronic sinus infection, the drugmakers said on Friday. ...
BRIEF-US FTC Says It Approves Final Divestiture Order In Synopsys And Ansys Deal
BRIEF-US FTC Says It Approves Final Divestiture Order In Synopsys And Ansys Deal
Oct 17, 2025
Oct 17 (Reuters) - * U.S. FTC SAYS IT APPROVES FINAL DIVESTITURE ORDER IN SYNOPSYS AND ANSYS DEAL * U.S. FTC SAYS IT APPROVES FINAL DIVESTITURE ORDER IN SYNOPSYS AND ANSYS DEAL Source text: https://www.ftc.gov/news-events/news/press-releases/2025/10/ftc-approves-final-divestiture-order-synopsys-ansys-deal Further company coverage: ...
Oracle's Long-Term Outlook Likely Disappointed Some Investors, UBS Says
Oracle's Long-Term Outlook Likely Disappointed Some Investors, UBS Says
Oct 17, 2025
04:12 PM EDT, 10/17/2025 (MT Newswires) -- Oracle's (ORCL) long-term outlook may have disappointed some investors, but there are reasons to own the cloud computing company's stock, UBS Securities said in a Friday note. Shares of Oracle declined 6.9% on Friday after the company said on Thursday it was aiming for earnings of $21 per share by fiscal 2030 and...
Northeast Recovery LLC Announces Acquisition of Collateral from Ark National Holdings LLC Pursuant to UCC 9-620
Northeast Recovery LLC Announces Acquisition of Collateral from Ark National Holdings LLC Pursuant to UCC 9-620
Oct 17, 2025
QUINCY, Mass., Oct. 17, 2025 /PRNewswire/ -- Northeast Recovery LLC (Northeast Recovery) today announced that it has completed a debt-for-assets transaction with Ark National Holdings LLC (Ark Behavioral Health), a leading provider of clinical, medical, and psychiatric care for substance use, mental health, and co-occurring disorders in Massachusetts. Pursuant to the transaction, consummated pursuant to Section 9-620 of the Uniform...
Copyright 2023-2026 - www.financetom.com All Rights Reserved